'Quality of pain' in systemic sclerosis

Rheumatology

Volumn 45, Issue 10, 2006, Pages 1185-1186

  Carreira, Patricia E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DISABILITY; DISEASE ACTIVITY; DISEASE SEVERITY; EDITORIAL; HUMAN; MUSCULOSKELETAL DISEASE; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SHORT FORM 36; SYSTEMIC SCLEROSIS; VISUAL ANALOG SCALE;

HEALTH STATUS INDICATORS; HUMANS; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC;

EID: 33749585272     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel247     Document Type: Editorial

References (13)

1. Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48:1530-42.
2. Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005;23(suppl 39):S14-S18.
3. Ware JE Jr, Sherbourne CD. The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
4. Wolfe F, Michaud K, Pincus T. Development and validation of the Health Assessment Questionnaire II. A revised version of the Health Assessment Questionnaire. Arthritis Rheum 2004;50: 3296-305.
5. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scale to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
6. Georges C, Chassany O, Mouthon L et al. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 2005;24:3-10.
7. Georges C, Chassany O, Toledano C et al. Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology 2006 June 4 [Epub ahead of print].
8. Richards HL, Herrick AL, Griffin K, Gwilliam PDH, Loukes J, Fortune DG. Systemic sclerosis: Patients' perceptions of their condition. Arthritis Care Res 2003;49:689-96.
9. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ et al. The impact of pain and symptoms of depression in scleroderma. Pain 2002;95:267-75.
10. Medsger T, Silman A, Steen V et al. A disease severity scale for systemic sclerosis: Development and testing. J Rheumatol 1999;26:2159-67.
11. Johnson SR, Lee P. The HAQ disability index in scleroderma trials. Rheumatology 2004;43:1200-1.
12. Pincus T, Sokka T. Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care. Clin Exp Rheumatol 2005;23(suppl 39):S1-S9.
13. Valentini G, Bencivelli W, Bombardieri S et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003;62:901-3.